Medicare Enrolled

Dr. Andres Soriano, M.D.

Hematology · North Venice, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5500 PINEBROOK RD STE 202, North Venice, FL 34275
9414080500
In practice since 2007 (18 years)
NPI: 1528269917 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Soriano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soriano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Soriano

Dr. Andres Soriano is a hematology in North Venice, FL, with 18 years in practice. Based on federal Medicare data, Dr. Soriano performed 266,807 Medicare services across 6,094 unique beneficiaries.

Between the years covered by Open Payments, Dr. Soriano received a total of $12,164 from 75 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Soriano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 10% volume in FL$ $12,164 industry payments

Medicare Practice Summary

Medicare Utilization ↗
266,807
Medicare services
Top 10% in FL for hematology
6,094
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,823 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)87,210$0$4
Pembrolizumab injection (Keytruda)22,800$43$137
Azacitidine chemotherapy injection22,200$0$4
Epoetin alfa injection (Procrit) for anemia21,671$6$23
Anti-nausea injection (aprepitant)18,330$1$5
Iron infusion (Injectafer)17,250$1$3
Oxaliplatin chemotherapy injection11,600$0$12
Denosumab injection (Prolia/Xgeva)10,920$18$51
Immune globulin infusion (Gammagard)9,252$36$108
Iron sucrose injection (Venofer)7,984$0$5
Iron infusion (Monoferric)7,300$16$57
Dexamethasone injection (steroid)3,947$0$3
Complete blood count (CBC) with differential3,549$8$29
Blood draw (venipuncture)3,423$8$9
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg2,460$24$185
Anti-nausea injection (Aloxi/palonosetron)1,900$1$28
Office visit, established patient (30-39 min)1,896$97$339
Anti-nausea injection (ondansetron/Zofran)1,324$0$9
Contrast dye for imaging (iodine-based)1,161$0$1
Injection of additional new drug or substance into vein1,117$12$61
Drug injection, under skin or into muscle1,048$10$69
Injection, leucovorin calcium, per 50 mg1,034$3$12
Administration of chemotherapy into vein, 1 hour or less706$97$378
Injection, fluorouracil, 500 mg674$2$7
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less536$47$189
Injection, zoledronic acid, 1 mg429$6$69
Injection, carboplatin, 50 mg348$2$41
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg280$3$205
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional278$16$59
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour274$15$56
Injection, diphenhydramine hcl, up to 50 mg266$1$3
Office visit, established patient (20-29 min)249$64$239
Injection, cisplatin, powder or solution, 10 mg249$2$13
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less241$22$84
Infusion into a vein for hydration, each additional hour208$10$42
Office visit, established patient, complex (40-54 min)192$138$474
Administration of additional new drug or substance into vein, 1 hour or less186$48$178
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle185$54$206
Injection of drug or substance into vein182$28$156
Administration of chemotherapy into vein, each additional hour179$21$79
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg177$1$6
Injection, methylprednisolone sodium succinate, up to 40 mg171$3$11
Infusion, normal saline solution , 1000 cc128$2$7
New patient office visit (45-59 min)121$126$453
Injection, magnesium sulfate, per 500 mg114$1$2
Prothrombin time test (blood clotting)104$4$15
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle101$24$89
Red blood count automated, with additional calculations96$5$20
New patient office visit, complex (60-74 min)87$162$585
Leuprolide acetate (for depot suspension), 7.5 mg84$135$562
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l81$129$637
Administration of additional new drug or substance into vein using push technique70$42$170
Automated urinalysis63$2$8
Initial hospital admission, high complexity62$136$556
Infusion into a vein for hydration, 31-60 minutes58$24$156
Hospital follow-up visit, moderate complexity57$63$197
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion51$15$56
Drawing of blood for a medical problem35$72$277
Infusion, normal saline solution, sterile (500 ml = 1 unit)35$1$7
Injection, alteplase recombinant, 1 mg26$69$218
Hospital follow-up visit, high complexity22$94$285
Ct scan of chest with contrast14$54$359
CT scan of abdomen and pelvis with contrast12$174$550
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.0% high complexity
50.1% medium
4.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,164
Total received (2018-2024)
Avg $1,738/year across 7 years
Top 38% in FL for hematology
75
Companies
616
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,228 (92.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$937 (7.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,198
2023
$2,355
2022
$1,832
2021
$62
2020
$423
2019
$1,888
2018
$2,407

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,117
E.R. Squibb & Sons, L.L.C.
$1,070
Novartis Pharmaceuticals Corporation
$991
Lilly USA, LLC
$739
Merck Sharp & Dohme Corporation
$645
Janssen Biotech, Inc.
$601
Celgene Corporation
$569
Daiichi Sankyo Inc.
$546
Genentech USA, Inc.
$431
Merck Sharp & Dohme LLC
$430
Incyte Corporation
$419
Astellas Pharma US Inc
$335
Gilead Sciences, Inc.
$316
AstraZeneca Pharmaceuticals LP
$262
Amgen Inc.
$215
Takeda Pharmaceuticals U.S.A., Inc.
$198
GENZYME CORPORATION
$198
ABBVIE INC.
$184
INTUITIVE SURGICAL, INC.
$172
Seagen Inc.
$171
Exelixis Inc.
$164
GlaxoSmithKline, LLC.
$146
Pharmacyclics LLC, An AbbVie Company
$139
BeiGene USA, Inc.
$112
EMD Serono, Inc.
$108
SOBI, INC
$91
Eisai Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$81
Janssen Scientific Affairs, LLC
$81
Puma Biotechnology, Inc.
$74
Kite Pharma, Inc.
$61
AbbVie, Inc.
$58
Dendreon Pharmaceuticals LLC
$57
Bayer Healthcare Pharmaceuticals Inc.
$56
ARRAY BIOPHARMA INC
$54
JAZZ PHARMACEUTICALS INC.
$54
CTI BioPharma Corp.
$54
TerSera Therapeutics LLC
$53
Stemline Therapeutics Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Sumitomo Pharma America, Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$47
AVEO Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$40
ADC Therapeutics America, Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$38
Myovant Sciences Inc.
$38
Lexicon Pharmaceuticals, Inc.
$37
Agios Pharmaceuticals, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$35
Blueprint Medicines Corporation
$35
Rigel Pharmaceuticals, Inc.
$34
Taiho Oncology, Inc.
$34
Karyopharm Therapeutics Inc.
$33
TAIHO ONCOLOGY, INC.
$30
SpringWorks Therapeutics, Inc.
$29
Innate Pharma, Inc
$24
Pharmacosmos Therapeutics Inc.
$23
EISAI INC.
$23
Ipsen Biopharmaceuticals, Inc
$22
Heron Therapeutics, Inc.
$22
GE HealthCare
$19
MorphoSys, US Inc.
$18
Acrotech Biopharma Inc.
$17
Acrotech Biopharma LLC
$17
Partner Therapeutics, Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$16
G1 Therapeutics, Inc.
$16
Epizyme, Inc.,
$16
Array BioPharma Inc.
$15
R-Pharm US LLC
$14
Sirtex Medical Inc
$13
Kyowa Kirin, Inc.
$12
Spectrum Pharmaceuticals Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FARESTON · FASENRA · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tarceva · Tavalisse · Trodelvy · UBRELVY · VARUBI · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xofigo · Xolair · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $5 per 100 Medicare services performed
Looking for a hematology in North Venice?
Compare hematologys in the North Venice area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
23
Per 100K population
5.1
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Soriano is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Soriano experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Soriano performed 87,210 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soriano receive payments from pharmaceutical companies?
Yes. Dr. Soriano received a total of $12,164 from 75 companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soriano's costs compare to other hematologys in North Venice?
Dr. Soriano's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soriano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →